TaTME (transanal total mesorectal excision) – state of the art

Česká verzia

Authors: P. Ihnát ^1,2
Authors place of work: Chirurgická klinika Fakultní nemocnice Ostrava ¹; Katedra chirurgických studií, Lékařská fakulta ²
Published in the journal: Rozhl. Chir., 2021, roč. 100, č. 11, s. 522-526.
Category: Review
doi: https://doi.org/10.33699/PIS.2021.100.11.522–526

Summary

Transanal total mesorectal excision (TaTME) is a modern hybrid method, which has emerged by conjunction of two minimally invasive techniques – laparoscopy and transanal minimally invasive surgery. The main aim of the method is to offer a better operative approach into the narrow pelvis and thus to support an oncosurgically radical TME. Mesorectal excision is performed transanally via a flexible single port platform. Safe implementation of the technique requires advanced skills in minimally invasive surgery, transanal endoscopic surgery as well as experience with surgical dissection from different points of view. Controversial results regarding TaTME in the available literature suggest that oncosurgical radicality of the method has to be examined by prospective clinical studies. Currently, two randomised studies (COLOR III and ETAP-GRECCAR 11) are ongoing which might soon clarify a proper position of TaTME in clinical practice.

Keywords:

rectal cancer – Minimally invasive surgery – local recurrence – total mesorectal excision – transanal – sphincter-saving resection

Zdroje

1. Herzogn T, Belyaev O, Chromik AM, et al. TME quality in rectal cancer surgery. Eur J Med Res. 2010;15(7):292–296. doi:10.1186/2047-783x-15-7-292.

2. Ihnát P, Delongová P, Horáček J, et al. The impact of standard protocol implementation on the quality of colorectal cancer pathology reporting. World J Surg. 2015;39(1):259−65. doi:10.1007/s00268- 014-2796-4.

3. Glynne-Jones R, Wyrwicz L, Tiret E, et al. ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2018;29(Suppl 4):iv263. doi:10.1093/annonc/mdy161.

4. Heald RJ, Moran BJ, Ryall RDH, et al. The Basingstoke experience of total mesorectal excision, 1978–1997. Arch Surg. 1998;133:894–899. doi:10.1001/archsurg. 133.8.894.

5. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery – the clue to pelvic recurrence? Br J Surg. 1982;69(10):613–616. doi:10.1002/ bjs.1800691019.

6. Whiteford MH. Local excision of rectal neoplasia. In: Steele SR, et al. The ASCRS textbook of colon and rectal surgery. 3rd ed. New York, Springer 2016:495–506. ISBN 978-3-319-25968-0.

7. Ihnát P, Martínek L, Ihnát Rudinská L, et al. Circumferential resection margin in the modern treatment of rectal cancer. Rozhl Chir. 2013;92(6):297−303. PMID: 23965313.

8. Pahlman L. Rectal cancer. In: Herold A, Lehur PA, Matzel KE, et al. European manual of medicine: Coloproctology. 1st ed. Berlin, Springer 2008:213–218. ISBN 978-3- 540-71216-9.

9. Hermanek P, Junginger T. The circumferential resection margin in rectal carcinoma surgery. Tech Coloproctol. 2005;9:193–200. doi:10.1007/s10151- 005-0226-1.

10. Trepanier JS, Lacy FB, Lacy AM. Transanal total mesorectal excision: Description of the technique. Clin Colon Rectal Surg. 2020;33(3):144–149. doi:10.1055/s-0039-3402777.

11. Ma B, Gao P, Song Y, et al. Transanal total mesorectal excision (taTME) for rectal cancer: a systematic review and meta- analysis of oncological and perioperative outcomes compared with laparoscopic total mesorectal excision. BMC Cancer 2016;16:380. doi:10.1186/s12885- 016-2428-5.

12. Prochazka V, Grolich T, Farkašova M, et al. Naše zkušenosti s transanální totální mezorektální excizí (TaTME) u tumorů středního a distálního rekta. Rozhl Chir. 2020;99(3):124–130. doi: 10.33699/ PIS.2020.99.3.124-130.

13. Lacy AM, Rattner DW, Adelsdorfer C, et al. Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: “down-to-up“ total mesorectal excision (TME) short-term outcomes in the first 20 cases. Surg Endosc. 2013;27:3165– 3172. doi: 10.1007/s00464-013-2872-0.

14. Adamina M, Buchs NC, Penna M, et al. St. Gallen consensus on safe implementation of transanal total mesorectal excision. Surg Endosc 2018;32(3):1091–1103. doi:10.1007/s00464-017-5990-2.

15. TaTME Guidance Group representing the ESCP (European Society of Coloproctology), et al. International expert consensus guidance on indications, implementation and quality measures for transanal total mesorectal excision. Colorectal Dis. 2020;22(7):749−755. doi:10.1111/ codi.15147.

16. Emile SH, de Lacy FB, Keller DS, et al. Evolution of transanal total mesorectal excision for rectal cancer: From top to bottom. World J Gastrointest Surg. 2018;10(3):28–39. doi:10.4240/wjgs.v10. i3.28.

17. Veltcamp Helbach M, Koedam TWA, Knol JJ, et al. Residual mesorectum on postoperative magnetic resonance imaging following transanal total mesorectal excision (TaTME) and laparoscopic total mesorectal excision (LapTME) in rectal cancer. Surg Endosc. 2019;33(1):94–102. doi:10.1007/s00464-018-6279-9.

18. Penna M, Hompes R, Arnold S, et al. Incidence and risk factors for anastomotic failure in 1594 patients treated by transanal total mesorectal excision: Results from the International TaTME Registry. Ann Surg. 2019;269(4):700–711. doi:10.1097/SLA.0000000000002653.

19. Larsen SG, Pfeffer F, Korner H. Norwegian Colorectal Cancer Group. Norwegian moratorium on transanal total mesorectal excision. Br J Surg. 2019;106(9):1120– 1121. doi:10.1002/bjs.11287.

20. van Oostendorp SE, Belgers HJ, Bootsma BT, et al. Locoregional recurrences after transanal total mesorectal excision of rectal cancer during implementation. Br J Surg. 2020;107(9):1211–1220. doi:10.1002/bjs.11525.

21. Ose I, Perdawood SK. A nationwide comparison of short-term outcomes after transanal, open, laparoscopic, and robot- assisted total mesorectal excision. Colorectal Dis. 2021;23:2671−2680. doi:10.1111/codi.15809.

22. Hajibandeh S, Hajibandeh S, Eltair M, et al. Meta-analysis of transanal total mesorectal excision versus laparoscopic total mesorectal excision in management of rectal cancer. Int J Colorectal Dis. 2020; 35(4):575–593. doi:10.1007/s00384-020- 03545-7.

23. Roodbeen SX, de Lacy FB, van Dieren S, et al. Predictive factors and risk model for positive circumferential resection margin rate after transanal total mesorectal excision in 2653 patients with rectal cancer. Ann Surg. 2019; 270(5):884–891. doi: 10.1097/SLA.0000000000003516.

24. International expert consensus guidance on indications, implementation and quality measures for transanal total mesorectal excision.